SERUM 2‐HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS. (June 2017) - Broutin, S.; Dupuy, A.; Koscielny, S.; Fataccioli, V.; Lemonnier, F.; de Leval, L.; Robe, C.; Pujals, A.; Safar, V.; Delarue, R.; Delfau‐Larue, M.H.; Ribrag, V.; et al.